Intrinsiqq
Quoin Pharmaceuticals Ltd. logo

Quoin Pharmaceuticals Ltd. Insider Trading

QNRX

Compare
Cluster buy

4 insiders bought 280K of their own stock in 1 day.

Open-market purchases by executives and directors between Aug 31 and Aug 31. Buying is rarer than selling and says more, but it is one input, not a verdict.

Net open-market
+280K
4 buys · 0 sales
Under a 10b5-1 plan
—
no sales
Insiders who bought / sold
4 / 0
executives and directors
Last open-market buy
Aug 2026
Aug 31, 2026

Get an email when QNRX's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Aug 31
    Denise P. Carter
    Chief Operating Officer · bought 20,490 at $4.88
    100K
    119% of stake
  • Aug 31
    Michael Myers
    Chief Executive Officer · bought 20,490 at $4.88
    100K
    119% of stake
  • Aug 31
    Sally Bridget Lawlor
    Chief Financial Officer · bought 10,244 at $4.88
    50K
    2328% of stake
  • Aug 31
    Anthony James Culverwell
    Director · bought 6,146 at $4.88
    30K
    18% of stake
  • Oct 14, 2025
    Dennis Langer
    Director · bought 15,152 at $8.49
    129K
    1515200% of stake
  • Dec 23, 2024
    Denise P. Carter
    Chief Operating Officer · bought 555,556 at $0.45
    250K
    1180% of stake
  • Dec 23, 2024
    Michael Myers
    Chief Executive Officer · bought 555,556 at $0.45
    250K
    1176% of stake
  • Dec 23, 2024
    Gordon Dunn
    Chief Financial Officer · bought 122,221 at $0.45
    55K
    424% of stake
  • Dec 23, 2024
    Anthony James Culverwell
    Director · bought 100,000 at $0.45
    45K
    31546% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch QNRX, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with QNRX

CompareIntrinsic value
LPCNLipocine Inc.
$1.50+0.00%40
IGCIGC Pharma Inc.
$0.17-6.67%26
FLNAFilana Therapeutics, Inc.
$0.64+14.29%40
ETSTEarth Science Tech Inc.
$0.09-2.16%66
CRVOCervoMed Inc.
$1.45+8.65%10
SCYXScynexis, Inc.
$2.38-8.64%40
ELTXElicio Therapeutics Inc.
$1.45-3.33%25
TENXTenax Therapeutics Inc.
$1.29-7.55%10

Spot a number that looks wrong? Check it in QNRX's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing QNRX

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.